[Conversion from typical to atypical neuroleptics. Guidelines for ambulatory and inpatient treatment].
The introduction of atypical antipsychotics has presented new options for the pharmacological treatment of schizophrenic patients. It is assumed that in the near future, neuroleptic medication will shift from conventional to atypical antipsychotics for an increasing number of patients. The present article addresses guidelines for the conversion from conventional to atypical neuroleptics in inpatient and outpatient settings.
Lambert
M
M
Klinik für Psychiatrie und Psychotherapie der Universität Hamburg. lambert@uke.uni-hamburg.de
Moritz
S
S
Haasen
C
C
Naber
D
D
D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D010343:Patient Admission; D017410:Practice Guidelines as Topic; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents